Abstract
During its short life time evidence-based medicine (EbM) has been subject of partly fierce criticism, mainly from the side of the clinic. In Germany, Rogler and Schölmerich (September 2000) published a critical commentary on EbM in the Deutsche Medizinische Wochenschrift. Our text is intended as a rejoinder. It firstly aims at clarifying the concept of EbM, especially its contribution to the science of clinical medicine, and it secondly answers relevant details of Rogler and Schölmerich's criticism. Their text turns out to be a mixture of truely relevant remarks, exaggerations, misunderstandings and obvious errors.
| Translated title of the contribution | Clinical medicine will be a science or it will not be |
|---|---|
| Original language | German |
| Journal | Zeitschrift fur Arztliche Fortbildung und Qualitatssicherung |
| Volume | 95 |
| Issue number | 7 |
| Pages (from-to) | 495-501 |
| Number of pages | 7 |
| ISSN | 1431-7621 |
| Publication status | Published - 2001 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Clinical medicine will be a science or it will not be'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver